Document is current
Any future updates will be listed below
-
Authors
Bazdyrev, Evgeny https://orcid.org/0000-0002-3023-6239
Panova, Maria https://orcid.org/0000-0002-0778-2389
Brachs, Maria https://orcid.org/0000-0001-9255-5131
Smolyarchuk, Elena https://orcid.org/0000-0002-2615-7167
Tsygankova, Daria https://orcid.org/0000-0001-6136-0518
Gofman, Liudmila https://orcid.org/0000-0001-6867-5694
Abdyusheva, Yana https://orcid.org/0000-0002-2611-8133
Novikov, Fedor https://orcid.org/0000-0001-5343-7722
-
Funding
Funding for this research was provided by:
pharmenterprises
- License Information
-
More Information
Article History
Received: 14 July 2022
Accepted: 21 September 2022
First Online: 3 November 2022
Declarations
:
: The authors declare that they have no conflicts of interest.
: COVID-TRE-03 was approved for all Russian centers by the National Ministry of Health on August 6th, 2020 (registry number 412/2020). The clinical study protocol and the informed consent form were approved by independent ethics committee and the study was done in accordance with the ethical principles of Good Clinical Practice and the Declaration of Helsinki. All participation in the study signed an informed consent in the prescribed form by the ethical committee of the Ministry of Health of the Russian Federation.
